InvestorsHub Logo
Followers 20
Posts 1390
Boards Moderated 0
Alias Born 06/16/2004

Re: Jayay222 post# 35280

Tuesday, 02/27/2018 2:04:29 PM

Tuesday, February 27, 2018 2:04:29 PM

Post# of 74766
I can't see KAST letting this thing go. I think there's a strong likelihood of them refiling the lawsuit. In my opinion it's not a matter of if it's when. That's what I took away from their PR.

Regardless, I didn't want to take the chance so I sold my position in VDRM yesterday. I already held it for a year waiting for something to materialize, only to watch the SP go down or sideways, and sell off quickly on every pop. That's OK for a trader, but I was in it for the long term so I never capitalized on any of those good days.

I started getting a little leery of the doctor because of the way he has been keeping shareholders in the dark regarding actual sales numbers. He's been selling product since November, yet so far no mention or any clue as to revenues. It seems to me if sales numbers were good top priority for him would be to let his investors know with some kind of proof. It would have done wonders for the share price of his company. A primary job of a CEO of a publicly traded company is to create shareholder value. How does keeping his shareholders in the dark regarding actual numbers accomplish that?

I sincerely hope that all the longs here do well with Viaderma. And more power to you for not giving up on them like I did. I'll be lurking on the sidelines for a while to see how things develop. I'm not against reopening a position if I like what I see. But I will wait for actual revenue numbers.

I'm most interested in their Canadian MMJ deal to see how that pans out. In my opinion that could be a better revenue generator than Vitastem sales.

Best of luck to all.